Early effects of sodium valproate monotherapy on serum paraoxonase/arylesterase activities

被引:22
作者
Karikas, George A. [2 ]
Schulpis, Kleopatra H. [3 ]
Bartzeliotou, Anastasia [1 ]
Regoutas, Spyros [4 ]
Thanopoulou, Christina [4 ]
Papaevangelou, Vassiliki [1 ]
Giannoulia-Karantana, Aglaia [3 ]
Papassotiriou, Ioannis [1 ]
Fytou-Pallikari, Athena [2 ]
机构
[1] Aghia Sophia Childrens Hosp, Dept Clin Biochem, Athens 11527, Greece
[2] Technol & Educ Inst Athens, Dept Med Labs, Athens, Greece
[3] Res Ctr, Inst Child Hlth, Athens, Greece
[4] Aghia Sophia Childrens Hosp, Parenteral Nutr & Pharmacokinet Unit, Athens 11527, Greece
关键词
Arylesterase; free radicals; paraoxonase1; valproate; ANTIEPILEPTIC DRUGS; OXIDATIVE STRESS; ACID; PARAOXONASE; LIPOPROTEIN; CHILDREN; LIPIDS;
D O I
10.1080/00365510802248051
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective . Valproic acid (VPA) treatment and paraoxonase1/arylesterase (PON1/Aryl) activities are related to the production of free radicals. Our aim was to study the PON1/Aryl activities in children on VPA therapy. Material and methods . Thirty-two children with seizures and 30 healthy child volunteers took part. Ill children underwent the common laboratory tests, as well as total antioxidant status (TAS), total oxidant status (TOS), lipid profile, liver enzymes and PON1/Aryl activities pre- and post-60 days on VPA therapy (30 mg/kg/24 h), whereas the healthy children were tested just once. Results . None of the studied biochemical parameters differed between volunteers and children with seizures pretreatment. Liver enzymes, lipids and TOS levels (12430 versus 58040 mol/L; p0.001) were significantly elevated, whereas the activities of PON1/Aryl (14643 versus 11840 U/mL/min 12042 versus 9838 KU/mL/min; p0.01) and TAS levels (43642 versus 28839 mol/L; p0.001) were decreased in children after treatment. Additionally, strong negative correlations were found between PON1/Aryl activities, liver enzymes, TOS (r=-0.69) and VPA levels (r=-0.57), whereas PON1/Aryl activities correlated positively with TAS, HDL and Apo A-I in all groups. Conclusions . Serum PON1/Aryl activities were decreased after 60 days on VPA treatment, probably due to liver dysfunction and free radicals production by VPA, without excluding the possibility of a direct action of the drug on the enzymes.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 29 条
[1]   Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities - Selective action of human paraoxonase allozymes Q and R [J].
Aviram, M ;
Billecke, S ;
Sorenson, R ;
Bisgaier, C ;
Newton, R ;
Rosenblat, M ;
Erogul, J ;
Hsu, C ;
Dunlop, C ;
La Du, B .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) :1617-1624
[2]   Valproic acid hepatic fatalities .3. US experience since 1986 [J].
Bryant, AE ;
Dreifuss, FE .
NEUROLOGY, 1996, 46 (02) :465-469
[3]  
CALABRESE JR, 1990, AM J PSYCHIAT, V147, P431
[4]   Semiautomated method for determination of serum paraoxonase activity using paraoxon as substrate [J].
Charlton-Menys, V ;
Liu, YF ;
Durrington, PN .
CLINICAL CHEMISTRY, 2006, 52 (03) :453-457
[5]  
Ferré N, 2002, CLIN CHEM, V48, P261
[6]   Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis [J].
Ferré, N ;
Camps, J ;
Cabré, M ;
Paul, A ;
Joven, J .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2001, 50 (09) :997-1000
[7]   Oxidants, oxidative stress and the biology of ageing [J].
Finkel, T ;
Holbrook, NJ .
NATURE, 2000, 408 (6809) :239-247
[8]   Antiepileptic drugs - From scientific evidence to clinical practice [J].
Garcia-Morales, Irene ;
Rieger, Jeronimo Sancho ;
Gil-Nagel, Antonio ;
Fernandez, Jose Luis Herranz .
NEUROLOGIST, 2007, 13 (06) :S20-S28
[9]  
GILFUMSHERKI Y, 2000, CURR STATE PHARM REV, V54, P271
[10]   Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers [J].
Gur, Mustafa ;
Yildiz, Ali ;
Demirbag, Recep ;
Yilmaz, Remzi ;
Aslan, Mehmet ;
Ozdogru, Ibrahim ;
Erel, Ozcan .
CORONARY ARTERY DISEASE, 2007, 18 (02) :89-95